Kodiak Sciences Inc
Kodiak Sciences Inc (KOD) Option Chain
As of September 22, 2026, Kodiak Sciences Inc is trading at $31.48, a -6.87% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 225.6%. IV Rank is 98%.
Read more
Tracking the KOD option chain helps you see every strike and expiry on Kodiak Sciences Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Kodiak Sciences Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of KOD options activity at a glance. Use our scanner to monitor the KOD option chain in real time and filter for the KOD options trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For KOD stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the KOD option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where KOD stock options are being actively traded and where they are not.
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as well as for the treatment of diabetic macular edema, naïve macular edema due to retinal vein occlusion, and non-proliferative diabetic retinopathy. The company's preclinical stage product candidate includes KSI-501, a bispecific conjugate to treat retinal diseases with an inflammatory component; and KSI-601, a triplet inhibitor for the treatment of dry AMD.
The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was incorporated in 2009 and is based in Palo Alto, California.
Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Kodiak Sciences Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen KOD options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of KOD stock options — let the full option chain come to you, pre-filtered and ready to trade.
Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV percentile98.81% Elevated
- Market cap (M$)2,124
- 52 weeks high-29.35%
- 52 weeks low208.96%
- Analyst recommendationStrong Buy
1.00 - Target price$69.60
121.09% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-12
- P/E—
- Future P/E—
- EPS (ttm)-4.19
- EPS growth next 5 years32.05%
As of September 22, 2026
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 50.66 | 0 | 0 | 7.87 | 2.48 | 8.70 | 12.00 | 29.00 | -14.20 | 4.70 | 5.70 | 0.00 | 5.20 | 11 | 14 | 49.34 |
| 53.01 | 19 | 0 | 8.47 | 1.48 | 8.20 | 11.70 | 30.00 | -11.24 | 5.30 | 6.90 | 0.00 | 6.10 | 14 | 356 | 46.99 |
| 55.27 | 68 | 0 | 8.67 | 0.48 | 7.70 | 10.60 | 31.00 | -8.28 | 5.50 | 7.60 | 0.00 | 6.55 | 2 | 8 | 44.73 |
| 57.45 | 102 | 100 | 8.60 | 0.00 | 7.20 | 10.00 | 32.00 | -5.33 | 6.40 | 7.40 | 0.52 | 6.38 | 3 | 128 | 42.55 |
| 59.53 | 1,068 | 55 | 8.70 | 0.00 | 7.20 | 10.20 | 33.00 | -2.37 | 7.10 | 9.30 | 1.52 | 6.68 | 112 | 14 | 40.47 |
As of September 22, 2026
Scan the full option chain in one place
Browse the full KOD option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.
Start your 14-day free trial→